
NeuBase Therapeutics Inc (NBSE)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy NBSE Stock
Start investing in NBSE
About NeuBase Therapeutics Inc (NBSE)
Market cap | — |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | — |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | — |
Today's range | — |
Debt / equity | — |
52 week range | $0.36 - $0.45 |
5 year debt / equity | — |
Beta (LTM) | -0.03x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 9, 2023 |
Dividend payable date | — |
NBSE Stock Rating
NBSE Stock News
View all



Frequently Asked Questions (FAQ)
How to buy NBSE stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in NBSE stock
Navigate to the Explore page. Then, type NBSE into the search bar. When you see NBSE stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased NBSE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
NeuBase Therapeutics Inc Stock Earnings
The value each NBSE share was expected to gain vs. the value that each NBSE share actually gained.
NBSE (NBSE) reported Q4 2023 earnings per share (EPS) of -$0.66, beating estimates of -$0.97 by 31.96%. In the same quarter last year, NBSE's earnings per share (EPS) was -$4.80. NBSE is expected to release next earnings on 11/09/2023, with an earnings per share (EPS) estimate of $0.